DCB Academy Symposium | CRT 2026
Join us at CRT 2026 for a focused scientific session dedicated to advancing the treatment of Complex Coronary Artery Disease, bridging evidence and real-world practice.
Monday, March 9, 2026
2:00 PM – 3:58 PM (EST)
📍 Spotlight Theater, Washington Hilton
Program Highlights:
• Comprehensive discussions on ISR and CTO management
• The evolving role of intravascular imaging
• AI applications in PCI
• Optimal lesion preparation for DCB
• A structured DCB vs DES debate
• 3 Live-in-the-Box sessions
• Multiple expert panels and case-based presentations
We leverage expert panels, case analyses and live demonstrations to turn cutting-edge evidence into optimized strategies for Drug-Coated Balloon therapy.
PICCOLETO IV–EPIC 38 officially underway – First Patient Enrolled
We are honored to announce the first patient enrollment by Dr. Davide Sala fromIstituto Auxologico Italiano- Ospedale San Luca in PICCOLETO IV – EPIC 38, an investigator-driven, multi-national RCT led by Fondazione RIC with the collaboration of Fundacion EPIC
We sincerely thank the team at Istituto Auxologico Italiano Ospedale San Luca for their outstanding dedication in making this significant progress possible
The trial will compare Single vs. Dual Antiplatelet Therapy (SAPT vs. DAPT) in high bleeding risk and elderly patients undergoing Drug-Coated Balloon (DCB) treatment, generating evidence to improve care for this vulnerable population
DEBS 2026 | Bridging Science and Clinical Excellence in DCB Therapy
DCB Academy and Fondazione RIC are proud to co-organize DEBS 2026, bringing together live cases, scientific insight, and real-world practice from 32 countries to advance the field of drug-coated balloon intervention!!
With sincere appreciation to Prof. Bernardo Cortese, Prof. Giuseppe M. Sangiorgi, and Dr. Daniela Benedetto, as well as the guest operators, Italian and international faculty, and the Global Advisory Board, for their outstanding leadership and dedication.
Honored to stand alongside the community in fostering education, innovation and the diffusion of best practices in interventional cardiology.
Live from DEBS 2026: Simultaneous Cases in Action
Experience real-time plaque modification and drug-coated balloon interventions at Tor Vergata University Hospital, Rome, guided by Prof. Cortese and Dr. G. Massaro
EuroPCR Joint Session | TRANSFORM II at DEBS 2026, Rome
How will TRANSFORM II change clinical practice?
“Leaving nothing behind” is more than a slogan, it reflects a true therapeutic evolution.
This Euro PCR joint session, led by Prof. Cortese, highlighted the evolving role of drug-coated balloons in coronary Interventions.
The focus was clear: refining techniques to reduce the need for long or multiple permanent stents while maintaining optimal efficacy.
Insightful expert discussions marked a strong first day at DEBS 2026, showcasing the latest innovations in DCB therapy alongside DCB
Academy and Fondazione RIC, in collaboration with Concept Medical.
Crystalline vs. Amorphous DCB
At DEBS Congress 2026, we had the privilege of presenting our PICCOLETO VI Mi.Re study insights on how the structural differences in drug-coated balloons can influence drug delivery, stability, and overall performance.
This work was proudly presented by DCB Academy and Fondazione Ricerca e Innovazione Cardiovascolare, in collaboration with Giada Barabaschi, Marcello Gramola, and Cardionovum.
Excited to continue advancing innovation in drug-coated balloon technology!
The First Asia-Pacific Stentless PCI Course | PCI Next: Think DCB 9–10 April 2026 | Hyatt Regency, Chennai, India
We are honored to present this landmark educational event on DCB-based, Stentless PCI, co-organized by DCB Academy and Fondazione RIC.
This comprehensive, evidence-driven programme, led by internationally renowned KOLs, is designed to provide practical, real-world insights spanning foundational principles, contemporary techniques, and advanced interventional strategies.
Join us in Chennai this April for two days of state-of-the-art learning, innovation, and multidisciplinary collaboration.
Course Directors: Dr. Rajinikanth Rajagopal, Prof. Bernardo Cortese, Dr. Girish Navasundi, Dr. Kumara Gurupparan, Dr. Sandeep Basavarajaiah, Dr. Bon-Kwon Koo, Dr. A B Gopalamurugan, Dr. Praveen Chandra, Dr. Upul Wickramarachchi, Prof. Bruno Scheller, Dr. Ho Hee Hwa, Dr. Do-Yoon Kang, Dr. Ho Lam, Dr. Rustem Dautov
PICCOLETO IV-EPIC featured in Cardiovascular News
The launch of PICCOLETO IV-EPIC, now featured in Cardiovascular News, marks a new chapter in interventional cardiology. This international, investigator-driven trial evaluates whether single-antiplatelet therapy (SAPT) following PCI with latest-generation drug-coated balloons (DCBs) can provide a safer and effective alternative for elderly patients and those at high bleeding risk.
Led by Fondazione RIC, DCB Academy and Fundación EPIC, PICCOLETO IV-EPIC addresses a key unmet need in high-risk coronary populations by exploring SAPT as an alternative to standard dual antiplatelet therapy.
Prof. Bernardo Cortese, Dr Armando Perez de Prado, Dr Chema de la torre hernandez, Dr Stefano De Servi Dr Manel Sabate
Fondazione RIC and DCB ACADEMY @JIMGISE Rome 2026
Opening Session on precision PCI in Complex CAD with insights from Prof. Bernardo Cortese, Dr. Waqas Mazhar, and the faculty, where imaging and physiology work together, clinical content matters, and risk-tailored PCI is key.
AI meets DCB angioplasty and the challenge is real! Our Golden Hour @JIMGISE Rome 2026
Our truly dynamic Golden Hour session at #JIMGISE Rome, where multimodality imaging, meticulous lesion assessment and AI-guided decision support came together to rethink strategy selection in contemporary PCI.
Led by Prof. Bernardo Cortese, with Prof. Alexandre Abizaid, Dr. Daniela Benedetto, Dr. Waqas Mazhar, and Eng. Dario Gattuso, this virtual tutored cath lab sparked an engaging, case based discussion, putting human expertise head to head with AI-informed guidance.
The key question remains: can AI become a true partner in optimizing DCB angioplasty?
Judging by today’s exchange, the future is already taking shape
Proudly supported by DCB ACADEMY, Fondazione RIC and Concept Medical
🎶 VuMedi: MUS.E I RCT | TCT 2025 🎶
We’re excited to share an exclusive VuMedi video featuring Prof. Bernardo Cortese, presenting the MUS.E I RCT study on the effects of music therapy during percutaneous coronary interventions (PCIs). Presented at TCT 2025, this innovative research explores the potential of music therapy as a non-pharmacological approach to reduce patient stress and improve cardiovascular outcomes. This study could redefine how we approach patient care in interventional cardiology. A special thanks to VuMedi for hosting this pivotal session and fostering important conversations in the field
VuMedi Exclusive: PICCOLETO X Clinical Trial | TCT 2025
DCB Academy Symposium with NFIC & the Polish Cardiac Society | Excellence in Interventional Cardiology
An expert-led, highly engaging, and scientifically rich symposium delivered in collaboration with NFIC and the Polish Cardiac Society.
The meeting brought together leading international experts to share the latest evidence and real-world experience on Drug-Coated Balloons (DCB) in complex coronary artery disease, addressing dissections, drug selection, advanced imaging and physiology, high-risk patient subsets, and state-of-the-art ISR management.
Faculty & Speakers: Bernardo Cortese, Fabrizio D’Ascenzo, Sylwia Iwańczyk, Marco Frazzetto, Pawel Gasior, Wojciech Wańha
Moderators: Dariusz Dudek, Maciej Lesiak, Wojciech Wańha, Zenon Huczek
Panelists: Robert J. Gil, Tomasz Pawlowski, Piotr Kwiatkowski, Piotr Wańczura, Michał Hawranek
An exceptional day at the DCB Academy Symposium during Zasink Congress 2025!
In the DCB Academy symposium, we explored cutting-edge clinical evidence, insights from PICCOLETO V and TRANSFORM II, and advanced procedural strategies, reinforcing drug-coated balloons (DCB) as a benchmark in complex coronary interventions.
Under the expert moderation of Prof. Bernardo Cortese, with contributions from Dr. Dobrin Vassilev, Dr. Eduard Margetic, Dr. Sinisa Stojkovic, Dr. Ivan Ilic, and panelists Dr. Wojciech Wańha, Dr. Waqas Mazhar, and Dr. Farhat Fouladvand, the session delivered an authoritative review of emerging clinical insights.
A special thank you to Dr. Vladimir Mitov and all faculty and panelists who made this high-level scientific exchange possible.
DCB Academy Symposium at Zasinsk Congress 2025 – Advanced Strategies for Complex Coronary Interventions 📍 Zasinsk Congress on Interventional Cardiology
A high-level scientific session dedicated to the evolving role of #DrugCoatedBalloons (DCB) in the management of complex coronary artery disease at Zasinsk Congress on Interventional Cardiology.
Under the moderation of Prof. Bernardo Cortese, together with Dr. Dobrin Vasilev, Dr. Eduard Margetic, Dr. Sinisa Stojkovic, and Dr. Ivan Ilić, the symposium will review state-of-the-art evidence and advanced procedural strategies across key PCI domains:
• Latest clinical data on DCB in coronary interventions
• Bifurcation management with DCB: insights from PICCOLETO V
• Contemporary approaches to in-stent restenosis (ISR) in 2025
• Strategies for diffuse coronary artery disease
Panelists: Dr. Wojtek Wańha • Dr. Waqas Mazhar • Dr. Fari Fouladvand
Aimed at advancing procedural strategy and optimizing clinical outcomes, this session will highlight the evolving evidence base and the technical nuances shaping next-generation DCB-guided PCI.
DCB Academy Masterclass | Active Side Branch Protection in Provisional Stenting
The latest DCB Academy lesson delivered a technically rigorous exploration of Active Side Branch Protection within a Provisional Stenting Strategy. Presented by our valued member Dr. Bharat Khialani, the session focused on procedural mechanics and evidence-based decision frameworks essential for preserving side branch integrity and minimizing compromise in complex bifurcation interventions.
Through case-based insights, the lesson illustrates real-world challenges, troubleshooting strategies, and decision-making algorithms, providing advanced, practical techniques to optimize outcomes while preserving side branch flow and procedural efficiency.
👉 Full Master Class
DCB Birmingham 2025 – The Premier Course on Drug-Coated Balloon Angioplasty 📍 Clayton Hotel Birmingham & Conference Centre, United Kingdom
This intensive, one-day advanced course is designed to master Drug-Coated Balloon (DCB) angioplasty across the full spectrum of clinical scenarios, from in-stent restenosis to complex de-novo lesions. Engage directly with world-renowned international faculty, gain cutting-edge insights, and refine your practical skills through interactive lectures, in-depth case discussions, and hands-on procedural strategies, all aimed at elevating your clinical practice.
Agenda Highlights:
Paclitaxel vs. Sirolimus: Which strategy is best for your patient?
DCB applications in de-novo lesions, ISR, bifurcations, ACS, and CTOs Technical mastery: lesion preparation, managing recoil, bailout strategies
Distinguished Faculty:
🌍 Prof. Bernardo Cortese | USA
🌍 Prof. Antonio Colombo | Italy
🌍 Prof. Bruno Scheller | Germany
🌍 Prof. David Hildick-Smith | UK
Course lead: Dr Sandeep Basavarajaiah, Heartlands Hospital
Honoured: our MUS.E I study makes TCTMD’s Top 10 Stories for October 2025
Honoured: our MUS.E I study makes TCTMD’s Top 10 Stories for October 2025! 🌟
Our MUS.E I trial, showing the transformative power of tailored music therapy before and during PCI, is now officially one of TCTMD’s most popular cardiovascular stories of the month, ranking #4 among global cardiology breakthroughs presented at TCT 2025 in San Francisco, CA.
This recognition highlights how an innovative, human-centred, non-pharmacological approach can transform the patient experience: reducing post-procedural blood pressure, heart rate, and pain, all while being safe, affordable, and patient-centred.
Being featured alongside groundbreaking innovations in thrombectomy, valve interventions, and novel PCI technologiesunderscores the growing appreciation for holistic, human-centered care in cardiology.
Next up: MUS.E II and beyond! We’ll continue exploring how music—and immersive virtual reality—can reduce stress and enhance outcomes during PCI, pushing the boundaries of patient-centred innovation in cardiology. The future of PCI care may start with a playlist. 🎵
Study Chairman: Prof. Bernardo Cortese
Our team: Rima Chaddad, MD; Marco Frazzetto, MD; Beatrice Barbano, MT; Sara Malakouti, MD; Irfan Ullah, MD; Cataldo Strangi
📖 Dive into TCTMD’s full story
From Music therapy to Stent-Free: DCB Academy at TCT 2025 — Driving Innovation, Collaboration, and Patient-Centered Care
What an inspiring week at TCT 2025 in San Francisco! We were honored to take part in the world’s leading interventional cardiology congress, presenting our research, exchanging ideas with global experts, and celebrating the innovation shaping the future of cardiovascular medicine. From groundbreaking studies to meaningful conversations, this year’s TCT highlighted the collective drive toward safer, smarter, and more compassionate patient care. A heartfelt thank you to our colleagues, partners, and friends who continue to push boundaries, share knowledge, and advance excellence in every aspect of our field. Together, we move forward — with purpose, passion, and a shared commitment to transforming cardiovascular care.
Masterclass Recording Now Live: Dr. Emmanouil S. Brilakis on CTO Revascularization
It is our privilege to release the full recording of our DCB Academy master lesson featuring Dr. Emmanouil (Manos) Brilakis, MD, PhD, a recognized authority in complex coronary intervention. In this session, Dr. Brilakis shares unparalleled insights on CTO revascularization, advanced procedural techniques, and Drug-Coated Balloon (DCB) integration, an invaluable learning opportunity for interventional cardiologists and cardiovascular professionals. With deep appreciation, we thank Dr. Emmanouil (Manos) Brilakis for sharing his expertise and dedication with the DCB Academy community.
🩺 PICCOLETO X Study: Pioneering Stent-Free Revascularization in Chronic Total Occlusions (CTO) 🩺
We are extremely honored to announce that the PICCOLETO X study “Stent-Free Revascularization in CTO: Clinical Performance of Drug-Coated Balloons in De Novo and ISR CTO” will be presented at TCT 2025 – Transcatheter Cardiovascular Therapeutics, taking place October 25-28 in San Francisco. Selected as Best Global Research in Coronary Studies, this landmark multicenter real-world study provides robust evidence supporting the safety and efficacy of #drugcoatedballoons (DCB) and reduced-metal strategies in complex coronary interventions, marking a significant advancement in cardiovascular therapeutics. As the landscape of coronary intervention continues to evolve, the PICCOLETO X study provides critical insights that promote precision, safety, and enhanced patient care in CTO revascularization.
📢 Exclusive Master Class Announcement 📢
We are extremely honored to present an exclusive Master Class on CTO Revascularization, featuring one of the foremost authorities in the field: Dr. Emmanouil (Manos) Brilakis
Topic: CTO Revascularization in 2025: Decision-Making, Techniques, and DCB Integration
🗓 Date: 21 October | 08:00 AM EST We are deeply grateful to Dr. Emmanouil (Manos) Brilakis for sharing his unparalleled expertise in this crucial area of cardiovascular care. During this session, Dr. Brilakis will explore the latest advancements in decision-making, cutting-edge techniques, and the integration of Drug-Coated Balloons (DCB), providing a comprehensive look at the future of CTO revascularization. This is an incredible opportunity to engage with one of the leaders shaping the future of interventional cardiology. We look forward to an insightful and inspiring discussion that will equip you with invaluable knowledge to apply in your practice.
🎶 MUS.E I RCT: Healing Hearts with Music 🎶
We are honored to announce that the results of the MUS.E I RCT “MUSic thErapy effects on the cardiovascular system during percutaneous coronary interventions” will be presented at TCT 2025 – Transcatheter Cardiovascular Therapeutics, on October 25-28 in San Francisco. Selected as Best Global Research in Coronary RCTs, this study pioneers the exploration of music therapy as a transformative adjunct in cardiovascular care. 🔍 Study Objectives:
➡️ To determine if music therapy reduces patient stress before and after percutaneous coronary interventions ➡️ To evaluate its impact on clinical and physiological cardiovascular outcomes during the procedure. In a landscape where cardiovascular disease remains the leading global cause of death, MUS.E I challenges traditional paradigms by integrating innovative, non-pharmacological interventions that enhance patient well-being and procedural success.
🚨 CALL FOR CLINICAL CASES – JIM GISE 2026 🚨
📍 Rome | 🗓️ February 4–6, 2026 📢 Deadline: 3 November 2025 JIM GISE Congress, in collaboration with DCB Academy, invites you to submit your most compelling complex or complication cases (coronary or structural) for the Clinical Case Competitions at #JIMGISE2026. 🏆 Why submit? Selected cases will be published in a dedicated online issue of AJC (minimum 8 cases) and in the CCI Case Reports section. Contributors will gain international visibility and be eligible for prestigious awards from JIM, SCAI, TCT, and CRT. Be part of a leading collaborative effort driving progress in interventional cardiology. 📍 Join world-leading experts. Share your experience. Elevate your impact. 🔗 Register 🕒 Early Bird Registration closes 9 January 2026 🔖 Follow & tag: JIM GISE 2026
📍Ixtapan de la Sal | 5 – 7 September 2025 Proud to be part to the first congress organized in Latin America dedicated to DCB – STRAT – CI 2025 Director: Dr. Josè Alfredo Merino Rajme | Co – Director: Dr. Carlos Alberto Zaragoza Cortés Chairmen: Prof. Bernardo Cortese | Dr. Neus Salvatella We are honored to announce the successful completion of enrollment in the OCT Sub-Study of TRANSFORM II, a landmark clinical trial evaluating Sirolimus-Coated Balloons (SCB) versus Drug-Eluting Stents (DES) in the treatment of native coronary artery disease. This global effort represents the highest standards of clinical excellence, driven by leading investigators across renowned institutions. We extend our sincere appreciation to these esteemed professionals for their unwavering dedication and invaluable contributions. 🔹 Dr. Carlos Campos – Instituto do Coração de São Paulo – FMUSP, Brazil 🔹 Dr. Ricardo Costa– Instituto Dante Pazzanese de Cardiologia, Brazil 🔹 Dr. Fernando Alfonso – Hospital de La Princesa, Madrid 🔹 Dr. Maarten A. Vink – OLVG, Amsterdam 🔹 Dr. Fazila Malik – National Heart Foundation, Bangladesh 🔹 Prof. Bernardo Cortese, Study Chairman. Led by the Fondazione Ricerca e Innovazione Cardiovascolare and DCB ACADEMY, the TRANSFORM II study continues to set new benchmarks in clinical excellence, coronary innovation, and global scientific leadership. Science in Action. Innovation in Care. Impact in Lives.
DCB – STRAT – CI 2025 Congress
📣A Landmark Achieved in Cardiovascular Innovation
CVI 2025 USA
A defining moment at CVI 2025 USA!
An appraisal on the most recent developments in Drug-Coated Balloons (DCB) for De Novo lesions by Prof. Bernardo Cortese. A compelling message on safety, efficacy, and innovation in the treatment of native coronary disease, delivered with precision, authority, and vision. Advance. Empower. Lead.
Exclusive Live Masterclass | DCB Academy
This focused masterclass explored the critical clinical decision-making process surrounding bailout stenting—examining when, why, and how to implement it following DCB angioplasty. The session featured in-depth discussion and expert insights from: Dr. Mauro Gitto and Dr. Filippo Luca Gurgoglione This live event offered valuable perspectives for interventional cardiologists facing real-world complexities in the cath lab.
A Key Moment from EuroPCR 2025
Prof. Bernardo Cortese, delivered a pivotal presentation on the MT Coronary Clinical Program: 12-Month Update, showcasing the latest clinical outcomes and innovations shaping the future of drug-coated balloon therapy. This important session, held in Paris, reflects our ongoing commitment to advancing interventional cardiology through data-driven research and real-world clinical impact.
DCB-PL Meeting: Advancing Clinical Precision in Interventional Cardiology
Precision. Expertise. Clinical Excellence. The DCB Academy-hosted session, Complex Case Discussions – Tips, Techniques & Perspectives, brought together leading clinicians for in-depth analysis of complex interventional cases. Focused on advancing clinical precision, the session offered practical insights, global perspectives, and evidence-based strategies that enriched peer-to-peer knowledge exchange.
DCB Academy at the XXIX Warsaw Course on Cardiovascular Interventions, hosted by the Polish Cardiac Society – A Moment of Transformation in Cardiovascular Care!
At DCB Academy, we had the privilege of leading a transformative session in collaboration with the Working Group of the Association of Cardiovascular Interventions of the Polish Cardiac Society. The spotlight was on Drug-Coated Balloons (DCB) and their pivotal role in reshaping the landscape of cardiovascular interventions. With contributions from world-renowned experts, including Prof. Bernardo Cortese, President of DCB Academy and Director and Professor of Medicine, Cleveland University Hospital, and Prof. Michał Hawranek, Prof. Zenon Huczek, as well as our DCB Academy fellows and members Dr. Wojciech Wańha, Dr. Sylwia Iwańczyk whose immense efforts and support were instrumental in organizing this session, along with the insightful presentations of Dr. Filippo Luca Gurgoglione, and Dr. Jasim Hasan, we delved into cutting-edge clinical evidence that is transforming patient outcomes and pushing the boundaries of innovation. A special thank you to the Polish Cardiac Society, our esteemed faculty, and all the participants whose insights and passion made this session truly exceptional. Together, we are accelerating progress in cardiovascular care!
DCB Academy at the XXIX Warsaw Course on Cardiovascular Interventions
We are pleased to announce that DCB Academy, in collaboration with the working group “Modern Technologies of Drug-Eluting Stents and Drug-Coated Balloons” of the Association of Cardiovascular Interventions of the Polish Cardiac Society, will be hosting an influential session at the XXIX Warsaw Course on Cardiovascular Interventions.
DCB Academy at Indian Live 2025
DCB Academy was proud to be part of Indian Live 2025, hosted by the International Cardiology Foundation of India. Our President, Prof. Cortese, led a session as a faculty member, sharing his expertise and insights with fellow cardiology professionals. It was a great opportunity to contribute to the advancement of the field and connect with global leaders.
DEBS Congress 2025: Live Case Presentation by President Prof. Cortese
Under the leadership of Prof. Bernardo Cortese, President of DCB Academy, a groundbreaking live case presentation was delivered at the DEBS Congress 2025. Prof. Cortese’s expert insights demonstrated the latest advancements in cardiovascular care, offering valuable, real-time guidance on complex clinical decision-making. This session provided attendees with hands-on experience and deepened the understanding of innovative techniques in cardiovascular medicine.
Trial Presentation at DEBS Congress 2025
At the DEBS Congress 2025, the largest congress in Europe dedicated to Drug-Coated Balloons (DCBs), DCB Academy and Fondazione RIC presented their latest clinical trial findings. This presentation highlighted groundbreaking research and innovative approaches in DCB technology, further advancing the field of cardiovascular interventions. The session sparked insightful discussions and reinforced the commitment to improving patient outcomes through cutting-edge treatments and collaboration in the cardiovascular community.
CRT Washington 2025
DCB Academy, in collaboration with University Hospitals Cleveland and led by Prof. Bernardo Cortese, proudly participated in CRT Washington 2025. We sponsored a key session highlighting the latest innovations in cardiovascular medicine. Our team delivered exceptional presentations that sparked meaningful discussions and contributed to the progress of the field. We extend our gratitude to all attendees and remain committed to advancing cardiovascular care and education for a healthier future.
DCB Academy at CRT Washington 2025
DCB Academy and University Hospitals Cleveland, under the leadership of Prof. Bernardo Cortese proudly participated in CRT Washington 2025, sponsoring a key session focused on cutting-edge advancements in cardiovascular medicine. Our esteemed fellows, Dr. Filippo Luca Gurgoglione and Dr. Marco Frazzetto delivered exceptional presentations that sparked valuable discussions and furthered innovation in the field. We extend our gratitude to all attendees and look forward to continuing our commitment to advancing cardiovascular care and education.
Leading the Charge with Drug-Coated Balloon Technology
DCB Academy proudly participated in the DEBS Congress 2025, Europe’s largest event dedicated to DCB technology. Among the many outstanding contributions, our fellow Dr. Filippo Luca Gurgoglione presented a compelling case on the use of Drug-Coated Balloons in complex lesions. The session was expertly moderated by Dr. Wojciech Wanha from DCB Academy, who guided the discussion with valuable insights and expertise. Dr. Gurgoglione’s presentation emphasized the transformative impact of DCB technology in improving procedural outcomes, particularly for high-risk patients.
A Day of Expertise and Visionary Leadership at JIMGISE 2025
At JIMGISE 2025, Prof. Bernardo Cortese, delivered a compelling presentation on Bifurcation with DCB, providing invaluable insights into one of the most intricate areas of interventional cardiology. His session highlighted cutting-edge techniques and their real-world applications, further advancing the field. In addition to his presentation, Prof. Cortese served as a distinguished panelist, contributing his expertise across multiple high-level discussions. His perspectives on device selection, procedural strategies, and clinical advancements reinforced his leadership in shaping the future of interventional cardiology.
Leading the Discussion on Advanced Lesion Preparation
DCB Academy proudly participated in the DEBS Congress 2025, the largest congress in Europe dedicated to DCB technology. Among the many key contributions, our fellow, Dr Leontin Lazar presented a highly impactful case on “Drug-Coated Balloons in CHIP Patients Lesion Preparation: Do It and Do It Hard!. Dr. Lazar‘s presentation underscored the critical importance of thorough lesion preparation in CHIP patients, highlighting the transformative potential of drug-coated balloons in improving procedural outcomes. His expertise reinforced how proper lesion preparation can optimize results for these high-risk patient populations.
DEB School XVIII in Ravenna
Under the esteemed leadership of Prof. Bernardo Cortese , President of DCB Academy, we had the honor of hosting DEB School XVIII in Ravenna. This event brought together renowned experts in cardiovascular medicine to share insights and foster innovation in the field.
DCB Academy at DEBS Congress 2025: Pioneering Advancements in Drug-Coated Balloon Technology
DCB Academy is honored to have collaborated with the DEBS Congress, Europe’s largest congress on Drug-Coated Balloons, to drive forward innovation and excellence in the fielo of interventional cardiology. With a robust presence at the congress, we proudly presented our pivotal multicenter randomized trials, showcased our groundbreaking clinical cases, and led insightful discussions on the future of DCB therapies. A huge thank you to all those who participated in these pivotal discussions and for making this collaboration a success. Together, we are advancing the future of treatment and patient outcomes.
DCB Academy at the Premier European Congress on Drug-Eluting Balloon Angioplasty: A Landmark Symposium for Advancing Interventional Cardiology
We are pleased to announce that DCB Academy will be hosting a groundbreaking symposium at the premier European Congress on Drug-Eluting Balloon (DEB) Angioplasty, set to take place in Rome on January 30-31. This event will serve as a unique platform for the global interventional cardiology community to engage in an advanced and comprehensive exploration of drug-coated balloon technology for coronary interventions. Featuring prominent thought leaders and key opinion leaders from around the world, the congress will showcase live case demonstrations, in-depth lectures, and dynamic discussions designed to elevate the scientific understanding and clinical application of DEB in the context of coronary artery disease. This congress represents an exceptional opportunity for both physicians and trainees to enhance their expertise and stay at the forefront of this rapidly evolving field.
